Search

everythinglearnresearchcommunity

for

Search:↓

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Baricitinib is effective for severe alopecia areata but has some side effects.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Baricitinib is effective and safe for treating severe alopecia areata.

Minoxidil effectively manages severe hypertension in hemodialysis patients with minimal side effects.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib is an effective treatment for severe alopecia areata.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.